{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:53:00Z","timestamp":1772254380958,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-024-02773-z","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:00:19Z","timestamp":1734526819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening for undiagnosed atrial fibrillation using an electronic health record\u2012based clinical prediction model: clinical pilot implementation initiative"],"prefix":"10.1186","volume":"24","author":[{"given":"Randall W.","family":"Grout","sequence":"first","affiliation":[]},{"given":"Mohammad","family":"Ateya","sequence":"additional","affiliation":[]},{"given":"Baely","family":"DiRenzo","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Hart","sequence":"additional","affiliation":[]},{"given":"Chase","family":"King","sequence":"additional","affiliation":[]},{"given":"Joshua","family":"Rajkumar","sequence":"additional","affiliation":[]},{"given":"Susan","family":"Sporrer","sequence":"additional","affiliation":[]},{"given":"Asad","family":"Torabi","sequence":"additional","affiliation":[]},{"given":"Todd A.","family":"Walroth","sequence":"additional","affiliation":[]},{"given":"Richard J.","family":"Kovacs","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"8","key":"2773_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","volume":"112","author":"S Colilla","year":"2013","unstructured":"Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142\u20137.","journal-title":"Am J Cardiol"},{"issue":"9","key":"2773_CR2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139\u2013596.","journal-title":"Circulation"},{"issue":"2","key":"2773_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","volume":"42","author":"LB Goldstein","year":"2011","unstructured":"Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(2):517\u201384.","journal-title":"Stroke"},{"issue":"1","key":"2773_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/STROKEAHA.112.676551","volume":"44","author":"G Saposnik","year":"2013","unstructured":"Saposnik G, Gladstone D, Raptis R, Zhou L, Hart RG. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke. 2013;44(1):99\u2013104.","journal-title":"Stroke"},{"issue":"6","key":"2773_CR5","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1161\/STROKEAHA.120.030812","volume":"52","author":"A Gabet","year":"2021","unstructured":"Gabet A, Guenancia C, Duloquin G, Olie V, Bejot Y. Ischemic stroke with atrial fibrillation: characteristics and time trends 2006 to 2017 in the Dijon Stroke Registry. Stroke. 2021;52(6):2077\u201385.","journal-title":"Stroke"},{"issue":"2","key":"2773_CR6","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm. Circulation. 2019;140(2):e125\u201351.","journal-title":"Circulation"},{"issue":"5","key":"2773_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/clc.23983","volume":"46","author":"MP Turakhia","year":"2023","unstructured":"Turakhia MP, Guo JD, Keshishian A, Delinger R, Sun X, Ferri M, et al. Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States. Clin Cardiol. 2023;46(5):484\u201393.","journal-title":"Clin Cardiol"},{"issue":"38","key":"2773_CR8","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962.","journal-title":"Eur Heart J"},{"key":"2773_CR9","doi-asserted-by":"publisher","first-page":"101757","DOI":"10.1016\/j.eclinm.2022.101757","volume":"55","author":"GF Romiti","year":"2023","unstructured":"Romiti GF, Proietti M, Bonini N, Ding WY, Boriani G, Huisman MV, et al. Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: a post-hoc analysis from the prospective GLORIA-AF registry. EClinicalMedicine. 2023;55:101757.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2773_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12911-021-01482-1","volume":"21","author":"RW Grout","year":"2021","unstructured":"Grout RW, Hui SL, Imler TD, El-Azab S, Baker J, Sands GH, et al. Development, validation, and proof-of-concept implementation of a two-year risk prediction model for undiagnosed atrial fibrillation using common electronic health data (UNAFIED). BMC Med Inf Decis Mak. 2021;21(1):112.","journal-title":"BMC Med Inf Decis Mak"},{"key":"2773_CR11","doi-asserted-by":"crossref","unstructured":"Longhurst CA, Singh K, Chopra A, Atreja A, Brownstein JS. A call for artificial intelligence implementation science centers to evaluate clinical effectiveness. New Engl J Med Artif Intell. 2024;1(8).","DOI":"10.1056\/AIp2400223"},{"issue":"2","key":"2773_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/ehjdh\/ztac009","volume":"3","author":"NR Hill","year":"2022","unstructured":"Hill NR, Groves L, Dickerson C, Ochs A, Pang D, Lawton S, et al. Identification of undiagnosed atrial fibrillation using a machine learning risk-prediction algorithm and diagnostic testing (PULsE-AI) in primary care: a multi-centre randomized controlled trial in England. Eur Heart J Digit Health. 2022;3(2):195\u2013204.","journal-title":"Eur Heart J Digit Health"},{"issue":"10","key":"2773_CR13","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","volume":"27","author":"D Brieger","year":"2018","unstructured":"Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, Connell C, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ. 2018;27(10):1209\u201366.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"2773_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCRESAHA.120.316341","volume":"127","author":"S Khurshid","year":"2020","unstructured":"Khurshid S, Healey JS, McIntyre WF, Lubitz SA. Population-based screening for atrial fibrillation. Circ Res. 2020;127(1):143\u201354.","journal-title":"Circ Res"},{"issue":"5","key":"2773_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jama.2018.10321","volume":"320","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for atrial fibrillation with electrocardiography: US preventive services task force recommendation statement. JAMA. 2018;320(5):478\u201384.","journal-title":"JAMA"},{"issue":"12","key":"2773_CR16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/europace\/euy117","volume":"20","author":"ME Middeldorp","year":"2018","unstructured":"Middeldorp ME, Pathak RK, Meredith M, Mehta AB, Elliott AD, Mahajan R, et al. PREVEntion and regReSsive effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. Europace. 2018;20(12):1929\u201335.","journal-title":"Europace"},{"issue":"1","key":"2773_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1817591","volume":"382","author":"A Voskoboinik","year":"2020","unstructured":"Voskoboinik A, Kalman JM, De Silva A, Nicholls T, Costello B, Nanayakkara S, et al. Alcohol abstinence in drinkers with atrial fibrillation. N Engl J Med. 2020;382(1):20\u20138.","journal-title":"N Engl J Med"},{"issue":"13","key":"2773_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","volume":"75","author":"Y Guo","year":"2020","unstructured":"Guo Y, Lane DA, Wang L, Zhang H, Wang H, Zhang W, et al. Mobile health technology to improve care for patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(13):1523\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"10310","key":"2773_CR19","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","volume":"398","author":"E Svennberg","year":"2021","unstructured":"Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M. Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. 2021;398(10310):1498\u2013506.","journal-title":"Lancet"},{"key":"2773_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2024.09.010","author":"M Ateya","year":"2024","unstructured":"Ateya M, Aristeridou D, Sands GH, Zielinski J, Grout RW, Colavecchia AC, et al. Validation, bias assessment, and optimization of the UNAFIED two-year risk prediction model for undiagnosed atrial fibrillation using national electronic health data. Heart Rhythm O2. 2024. https:\/\/doi.org\/10.1016\/j.hroo.2024.09.010. In press.","journal-title":"Heart Rhythm O2"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02773-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-024-02773-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02773-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:07:57Z","timestamp":1734527277000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-024-02773-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2773"],"URL":"https:\/\/doi.org\/10.1186\/s12911-024-02773-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The final protocol and any amendments were reviewed and approved by the Indiana University institutional review board (IRB) and Eskenazi Health. The IRBs waived the requirement of signed informed consent, but patients were provided an information sheet about the study and were allowed to decline enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.W. Grout, R.J. Kovacs, C. King, and A. Torabi are employees of Indiana University, which received financial support from Pfizer Inc. in connection with the execution of this study. J. Rajkumar was an employee of Eskenazi Health and B. DiRenzo and T.A. Walroth are employees of Eskenazi Health, which received financial support from Pfizer Inc. in connection with the execution of this study. M. Ateya, S. Hart, and S. Sporrer are employees of Pfizer Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}